Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Hematol Oncol ; 24(1): 69-73, 2007.
Article in English | MEDLINE | ID: mdl-17130116

ABSTRACT

Very few people do not express any Kell antigens on their red blood cells (K0 phenotype). They can be immunized by transfusion or pregnancy and develop antibodies against Kell system antigens. These maternal antibodies can cause severe hemolytic disease of the fetus/newborn, as a result of the suppression of erythropoiesis and hemolysis. Multiple intrauterine transfusions in the management of severe hemolytic disease have been shown to cause erythropoietic suppression as well. Recombinant erythropoietin has been successfully used in the management of late anemia of infants with Rh hemolytic disease and in 1 case of KEL1 (Kell)-associated hemolytic disease. The authors present the case of severe hemolytic disease of a newborn due to KEL5 (Ku) isoimmunization of his K0 phenotype mother. Regular intrauterine transfusions were performed to manage the severe fetal anemia (Hb 3 g/dL). A male infant was born at the 36th week of gestation having normal hemoglobin (15.8 g/dL) and developed only mild hyperbilirubinemia. On the 15th day of life, the infant's hematocrit had fallen to 27.3%, with low reticulocyte count and low erythropoietin level. The infant was managed successfully with recombinant erythropoietin.


Subject(s)
Erythroblastosis, Fetal/drug therapy , Erythropoietin/therapeutic use , Hematinics/therapeutic use , Adult , Erythroblastosis, Fetal/blood , Female , Humans , Infant, Newborn , Kell Blood-Group System , Male , Pregnancy , Recombinant Proteins
2.
Transfusion ; 45(11): 1791-5, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16271105

ABSTRACT

BACKGROUND: The management of a pregnant woman with the rare Ko phenotype and anti-Ku is a special challenge, because matched blood is extremely rare and the possibility of severe hemolytic disease of the newborn is high. CASE REPORT: A 30-year-old woman with rare Ko (Knull) phenotype presented at 18 weeks of gestation with positive indirect agglutination test results. She had anti-Ku due to previous blood transfusion, one pregnancy, and two abortions. STUDY DESIGN AND METHODS: During this pregnancy, anti-Ku titers ranged from 1024 to 4096. At the 26th week of gestation ultrasound showed a hydropic fetus and urgent intrauterine exchange transfusion was performed with the maternal red blood cells (RBCs). Recombinant human erythropoietin (rHu-EPO) and intravenous (IV) iron were administered to the mother to ensure an adequate supply of matched RBCs for intrauterine transfusions and possible perinatal hemorrhage. RESULTS: Intrauterine transfusions were repeated every 1 to 3 weeks. By 35 weeks 2 days of gestation, the mother had donated 4 units of blood, and four intrauterine transfusions had been performed. Cesarean section was then decided and a healthy male newborn was born. He was treated with phototherapy but without exchange transfusions. By the 15th day of life rHu-EPO was administrated to the newborn because of anemia. The maternal RBCs completely disappeared from the child's blood by Day 100. CONCLUSIONS: As shown in this case, treatment with rHu-EPO and IV Fe has effectively increased the mother's capacity to donate RBCs for autologous use and intrauterine transfusions, with no adverse effects to the mother or the child.


Subject(s)
Antigens, Nuclear/immunology , Blood Donors , Blood Transfusion, Intrauterine , DNA-Binding Proteins/immunology , Erythroblastosis, Fetal/therapy , Erythropoietin/therapeutic use , Pregnancy/blood , Adult , Anemia, Hemolytic/drug therapy , Anemia, Hemolytic/immunology , Cesarean Section , Erythroblastosis, Fetal/immunology , Erythroblastosis, Fetal/physiopathology , Female , Humans , Infant, Newborn , Isoantibodies/blood , Kell Blood-Group System/immunology , Ku Autoantigen , Male , Recombinant Proteins , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...